A human study to evaluate the bioavailability, anti-inflammation, and safety of Agastache rugosa extracts in healthy women aged more than 20 years and less than 30 years old.
- Conditions
- Not Applicable
- Registration Number
- KCT0006656
- Lead Sponsor
- Ewha Womens University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 10
1) Subject who voluntarily agree to participate and signs informed consent form
2) Subject who can participate in all visits (total of twice) after random assignment.
2) healthy women aged over 20 years old and under 40 years old
1) presence of disease :
chronic inflammatory disease, diabetes, liver or kidney disease, cardiovascular disease, uncontrolled hypertension (systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg), or thyroid disease, etc.
2) taking medication and oriental medicine that may affect antioxidant/anti-inflammatory properties, blood glucose and blood lipids within the preceding 4 weeks
3) continuous consumption of dietary supplements within the preceding 4 week
4) body mass index (BMI) of less than 18.5 kg/m2 or greater than 30 kg/m2
5) a history of body weight change = 4 kg within the preceding 4 weeks
6) alcoholism
7) smokers
8) subjects were unable to maintain their current lifestyle (exercise, diet, etc.) during the exam period
9) participation in another clinical trial within the preceding 4 weeks
10) pregnancy or lactation
11) hypersensitivity to Agastache rugosa or any ingredients in the study product
12) investigator’s determination of unsuitability for the trial
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Targeted metabolomics
- Secondary Outcome Measures
Name Time Method Proteomics;Biochemical markers: glucose, insulin, triglycerides, total cholesterol, free fatty acids etc.